BBIO STOCK ANALYSIS

BridgeBio Pharma Inc — price, returns and risk statistics

BBIOBridgeBio Pharma Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Last Close

77.19 $

Jul 2, 26

Market Cap

15 B $

Q1 2026 (TTM)

52-Week Range

Total Return

%+80.2

Trailing 1-year performance

Volatility

%46.2

Price fluctuation measure

Sharpe Ratio

0.65

Risk/Return ratio

Sortino Ratio

0.70

Downside risk/return

Distance to Peak

%-3.4

Difference from 52-week peak

Maximum Drawdown

-%20.2

Deepest 1-year decline

Seasonality Chart

Year 2023

Year 2024

Year 2025

Current Period 2026

3/3 positive months

Periodic Returns

+20.8%

+5.5%

+0.9%

YTD

+0.9%

+80.2%

+344.9%

Returns are computed from split-adjusted closes; dividends are not included.

YTD Return — Stock vs Asset Classes

Year-to-date

Stock and gold/silver returns are in USD (metals converted into the stock's currency). The S&P 500 index is measured in its own currency.

Monthly Avg Positive/Negative Close

Positive Count

Negative Count

Average Positive %

Average Negative %

Frequently Asked Questions

What is the current BridgeBio Pharma Inc (BBIO) stock price?

BBIO last closed at 77.19 $ (Jul 2, 26). Price data is refreshed after every trading day.

What is the market capitalization of BridgeBio Pharma Inc?

BridgeBio Pharma Inc (BBIO) has a market capitalization of approximately 15 B $ as of the latest reported period.

Who are the main competitors of BBIO?

Key peers of BridgeBio Pharma Inc include CSL Ltd, TELIX Pharmaceuticals Ltd, Mesoblast Ltd. A detailed metric comparison is available on the Peers tab.

Go deeper on BBIO

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.